Phytochemical Investigations and Anti-Cancer Applications of Hedyotis Diffusa

Hedyotis diffusa, a Rubiaceae herb long employed in traditional medicine, has been the subject of extensive phytochemical and pharmacological research aimed at elucidating its anti-cancer potential. To date, more than 170 compounds have been isolated, notably iridoid glycosides, flavonoids, anthraquinones and phenolic acids, each exhibiting diverse biological activities. Mechanistic studies have demonstrated that extracts and pure constituents of H. diffusa inhibit tumour growth by inducing apoptosis, arresting the cell cycle and impairing angiogenesis. Key molecular targets include the STAT3 signalling axis, which mediates survival and proliferation; the NF-κB and MAPK pathways, which regulate inflammatory mediators; and Wnt/β-catenin and apoptotic caspases. Network pharmacology approaches have revealed a multi‐target profile, highlighting bioactive ingredients such as quercetin and ursolic acid in modulating oncogenic networks. Advances in analytical methods—high‐performance liquid chromatography, mass spectrometry and fingerprinting—have improved quality control, yet standardised markers and pharmacokinetic data remain scarce. Together, these findings underscore the global significance of H. diffusa as a source for novel anti-cancer leads and as an adjuvant in integrative oncology, while emphasising the need for rigorous standardisation and clinical validation.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Phytochemical Investigations and Anti-Cancer Applications of Hedyotis Diffusa publication trend

The graph below shows the total number of articles in phytochemical investigations and anti-cancer applications of hedyotis diffusa across all publications each year (not limited to Nature Index journals).

Technical terms

Iridoid glycoside: A class of plant secondary metabolites combining an iridoid core with sugar moieties, often exhibiting anti-inflammatory and cytotoxic effects.

Flavonoid: Polyphenolic compounds characterised by a C6–C3–C6 skeleton, noted for antioxidant and anti-tumour activities.

STAT3: Signal Transducer and Activator of Transcription 3, a transcription factor central to cell proliferation, survival and inflammation.

Network pharmacology: An interdisciplinary approach that maps the interactions between phytochemicals and multiple biological targets to elucidate mechanisms of action.

Apoptosis: Programmed cell death involving caspase activation, chromatin condensation and DNA fragmentation, crucial for eliminating cancer cells.

References

1. Molecular mechanism of the treatment of lung adenocarcinoma by Hedyotis Diffusa: an integrative study with real-world clinical data and experimental validation. Frontiers in Pharmacology (2024).
2. The Hedyotis diffusa Willd. (Rubiaceae): A Review on Phytochemistry, Pharmacology, Quality Control and Pharmacokinetics. Molecules (2016).
3. Hedyotis diffusa Willd Inhibits Colorectal Cancer Growth in Vivo via Inhibition of STAT3 Signaling Pathway. International Journal of Molecular Sciences (2012).
4. Investigating the Multi-Target Pharmacological Mechanism of Hedyotis diffusa Willd Acting on Prostate Cancer: A Network Pharmacology Approach. Biomolecules (2019).